The clinical severity of Osteogenesis Imperfecta (OI), also known as the brittle bone disease, relates to the extent of conformational changes in the collagen triple helix induced by Gly substitution mutations. The lingering question is why Gly substitutions at different locations of collagen cause different disruptions of the triple helix. Here, we describe markedly different conformational changes of the triple helix induced by two Gly substitution mutations placed only 12 residues apart. The effects of the Gly substitutions were characterized using a recombinant collagen fragment modeling the 63-residue segment of the ␣1 chain of type I collagen containing no Hyp (residues 877-939) obtained from Escherichia coli. Two Gly 3 Ser substitutions at Gly-901 and Gly-913 associated with, respectively, mild and severe OI variants were introduced by site-directed mutagenesis. Biophysical characterization and limited protease digestion experiments revealed that while the substitution at Gly-901 causes relatively minor destabilization of the triple helix, the substitution at Gly-913 induces large scale unfolding of an unstable region C-terminal to the mutation site. This extensive unfolding is caused by the intrinsic low stability of the C-terminal region of the helix and the mutation induced disruption of a set of salt bridges, which functions to lock this unstable region into the triple helical conformation. The extensive conformational changes associated with the loss of the salt bridges highlight the long range impact of the local interactions of triple helix and suggest a new mechanism by which OI mutations cause severe conformational damages in collagen.Considerable effort has been made to elucidate the mechanisms by which Gly substitution mutations of the collagen triple helix cause Osteogenesis Imperfecta (OI), 2 also known as brittle bone disease. The collagen triple helix consists of three polypeptide chains each in extended polyproline II conformation and with the characteristic (Gly-X-Y) n repeating amino acid sequence (1-3). The Gly at every third position is necessitated by the close packing of the helix; while the X and Y residues (where X and Y can be any amino acids) contribute directlytothestabilityofthetriplehelixandconferthesequencedependent properties of collagen (4). Missense mutations that replace the obligatory Gly by another amino acid residue in type I collagen, the major component of bones, are the most common cause of OI (5, 6). The triple helix domain of type I collagen is a heterotrimer composed of two ␣1 chains and one ␣2 chain each with more than 1000 amino acids in an uninterrupted (Gly-X-Y) n sequence (7). Nearly 800 Gly replacing mutations from both ␣1 and ␣2 chains have been linked to OI, yet, depending on the location and the identity of the Gly substitution, the clinical severity of OI varies from mild increase of bone fragility to the most severe type characterized by death at the prenatal stage (the Type II OI) (6). It remains unclear what molecular properties are related to the se...